Precision Medicine Market Global Analysis and Forecast 2020-2030 | BIS Research
Title:
Precision Medicine Market Global Analysis and Forecast 2020-2030 | BIS Research
Description:
The global precision medicine market is expected to reach $278.61 billion by the end of 2030. The market is projected to grow at a CAGR of 11.13% during the forecast period, 2020-2030. Factors driving the growth of the market including advancement of sequencing technologies, rising prevalence of chronic diseases, growing demand for preventive care, and shifting the significance in medicine from reaction to prevention. – PowerPoint PPT presentation
Number of Views:4
Title: Precision Medicine Market Global Analysis and Forecast 2020-2030 | BIS Research
1
Global Precision Medicine Market
Focus on Ecosystem, Technology, Application,
Country Data (21 Countries), and Competitive
Landscape Analysis and Forecast
2020-2030 August-2020 TOC
2
Global Precision Medicine Market
BIS Research is a leading market intelligence and
technology research company. BIS Research
publishes in-depth market intelligence reports
focusing on the market estimations, technology
analysis, emerging high-growth applications,
deeply segmented granular country-level market
data and other important market parameters
useful in the strategic decision making for
senior management. BIS Research provides
multi-client reports, company profiles,
databases, and custom research services.
Copyright 2020 BIS Research Inc. All Rights
Reserved. This document contains highly
confidential information and is the sole property
of BIS Research. Disclosing, copying,
circulating, quoting, or otherwise reproducing
any or all contents of this document is strictly
prohibited. Access to this information is
provided exclusively for the benefit of the
people or organization concerned. It may not be
accessed by or offered whether for sale or
otherwise to any third party.
2
3
Global Precision Medicine Market
Table of Contents
- 1. Product Definition ............................
..................................................
...................... 48 - 1.1 Inclusion and Exclusion ......................
..................................................
......... 48 - 2. Research Scope.................................
..................................................
..................... 49 - 2.1 Scope of Study ...............................
..................................................
............... 49 - 2.2 Key Questions Answered in the Report
..................................................
...... 51 - 2.3 Global Precision Medicine Market Research
Methodology........................ 51
2.4 Criteria for Company Profiling
..................................................
..................... 52 - 3. Research Methodology ..........................
..................................................
................ 54 - 3.1 Primary Data Sources .........................
..................................................
.......... 54 - 3.2 Secondary Data Sources .......................
..................................................
....... 55 - 3.3 Market Estimation Model ......................
..................................................
........ 55 - 4. Global Precision Medicine Market
Overview..........................................
................ 58 4.1 Market Definition
..................................................
........................................... 58 - Precision Medicine A Frontier in the Genesis of
Patient-centric Medicine.........................
..................................................
................................ 59 - Precision Medicine Remodeling the
One-Size-Fits-All Theory to Individually
Tailored Therapy..................................
....................................... 61 - 4.4 Initiatives and Programs......................
..................................................
......... 62 - 4.5 Precision Medicine Enabling Technologies and
Applications................... 66
4.5.1 Innovators .................................
..................................................
...... 67 - 4.5.1.1 3D DNA Printing...........................
.................................................
67 - 4.5.1.1.1 Introduction ...........................
..................................................
............... 67 - 4.5.1.1.2 Role of 3D DNA Printing.................
..................................................
...... 68 - 4.5.1.2 RNA-Seq ..................................
..................................................
... 68
3
4
Global Precision Medicine Market
4.5.1.3.3 Key Players.............................
..................................................
............. 69 4.5.2 Early Adopters
..................................................
................................
70 4.5.2.1 CRISPR ................................
..................................................
...... 70 4.5.2.1.1 Introduction
..................................................
..........................................
70 4.5.2.1.2 Role of CRISPR in Precision
Medicine..........................................
......... 70 4.5.2.1.3 Key Players................
..................................................
.......................... 71 4.5.2.2 Blockchain..
..................................................
.................................
71 4.5.2.2.1 Introduction ........................
..................................................
.................. 71 4.5.2.2.2 Role of
Blockchain in Precision Medicine
...............................................
71 4.5.2.2.3 Key Players.........................
..................................................
................. 72 4.5.2.3 Imaging
Informatics.......................................
................................
72 4.5.2.3.1 Introduction ........................
..................................................
.................. 72 4.5.2.3.2 Role of Imaging
Informatics in Precision Medicine
................................. 72 4.5.2.3.3
Key Players.......................................
..................................................
... 73 4.5.3 Early Majority .....................
..................................................
............. 73 4.5.3.1 Artificial Intelligence
(AI)..............................................
.................. 73 4.5.3.1.1
Introduction .....................................
..................................................
..... 73 4.5.3.1.2 Role of Artificial
Intelligence in Precision Medicine
................................. 73 4.5.3.1.3
Key Players..................................
..................................................
........ 74 4.5.3.2 Circulating Free DNA
(cfDNA)...........................................
............ 74 4.5.3.2.1 Introduction
..................................................
..........................................
74 4.5.3.2.2 Role of cfDNA in Precision Medicine
..................................................
.... 74 4.5.3.2.3 Key Players.....................
..................................................
..................... 75 4.5.3.3 Big Data
..................................................
......................................
75 4.5.3.3.1 Introduction ........................
..................................................
.................. 75 4.5.3.3.2 Role of Big Data
in Precision Medicine.............................
...................... 75 4.5.3.3.3 Key
Players...........................................
.................................................
76 4.5.3.4 Next-Generation Sequencing
(NGS).............................................
77 4.5.3.4.1 Introduction .......................
..................................................
................... 77 4.5.3.4.2 Role of NGS in
Precision Medicine ...............................
......................... 77 4.5.3.4.3 Key
Players...........................................
.................................................
77 4.5.3.5 Health Informatics ....................
..................................................
... 78 4.5.3.5.1 Introduction ....................
..................................................
...................... 78 4.5.3.5.2 Role of
Health Informatics in Precision
Medicine.................................... 78
4
5
Global Precision Medicine Market
- 4.5.3.5.3 Key players ............................
..................................................
.............. 79 - 4.5.3.6 Bioinformatics............................
..................................................
.. 79 - 4.5.3.6.1 Introduction ...........................
..................................................
............... 79 - 4.5.3.6.2 Role of Bioinformatics in Precision
Medicine .........................................
. 80 4.5.3.6.3 Key Players.......................
..................................................
................... 80 4.5.4 Late Majority
..................................................
................................... 80 4.5.4.1
Polymerase Chain Reactions (PCR)
............................................. 80
4.5.4.1.1 Introduction ...........................
..................................................
............... 80 4.5.4.1.2 Role of PCR in
Precision Medicine................................
......................... 81 4.5.4.1.3 Key
players ..........................................
..................................................
81 4.5.4.2 Microarray ..........................
..................................................
......... 81 4.5.4.2.1 Role of Microarray in
Precision Medicine ...............................
................ 82 4.5.4.2.2 Key
Players...........................................
.................................................
83 - 4.6 COVID-19 Impact on the Global Precision
Medicine Market ....................... 83 - 5. Market Dynamics ...............................
..................................................
..................... 85 - 5.1 Overview .....................................
..................................................
................... 85 - 5.2 Market Drivers ...............................
..................................................
................ 87 - 5.2.1 Advancement of Sequencing Technologies
.................................. 87 5.2.2
Rising Prevalence of Chronic Diseases
......................................... 89
5.2.3 Growing Demand for Preventive Care
............................................ 91 - Shifting the Significance in Medicine, from
Reaction to - Prevention........................................
.................................................
92 - Reducing Adverse Drug Reactions Through
- Pharmacogenomics Test ............................
..................................... 92 - Potential to Reduce the Overall Healthcare Cost
Across the - Globe ............................................
..................................................
... 93 - 5.3 Market Restraints ............................
..................................................
.............. 94 - 5.3.1 Unified Framework for Data Integration
......................................... 94 - 5.3.2 Limited Knowledge about Molecular
Mechanism/ - Interaction ......................................
..................................................
. 94
5
6
Global Precision Medicine Market
- 5.4.2 Expansion into the Emerging Markets
........................................... 99 - 5.4.3 Collaboration and Partnerships Across Value
Chain to - Accelerate the Market Entry ......................
.................................... 100 - 6. Industry Insights..............................
..................................................
..................... 101 - 6.1 Patent Analysis ..............................
..................................................
............. 101 - 6.2 Legal Requirements and Regulations
..................................................
....... 102 - 6.3 Pipeline Analysis.............................
..................................................
............ 104 - 6.4 Legal Requirements and Framework by the
FDA....................................... 112 - 6.5 Legal Requirements and Framework by the EMA
...................................... 115 - 6.6 Legal Requirements and Framework by the MHLW
................................... 116 - 7. Competitive Landscape .........................
..................................................
.............. 118 - 7.1 Synergistic Activities .......................
..................................................
........... 119 - 7.1.1 Product launches, Enhancements, and
Upgradation.................. 121 7.1.2 Product
Approvals ........................................
................................. 122 7.1.3
Mergers and Acquisitions..........................
.................................... 123 7.1.4
Business Expansion ...........................
........................................... 125 - 7.2 Market Share Analysis .....................
..................................................
........... 126 - Market Share Analysis by Applied Sciences,
2019...................... 127 - Market Share Analysis by Precision Diagnostics,
2019 .............. 129 - Market Share Analysis by Precision Therapeutics,
2019............ 131 - Market Share Analysis by Digital Health and IT,
2019 ................. 133 - 8. Global Precision Medicine Market (by
Ecosystem) .......................................
...... 135 8.1 Overview .........................
..................................................
............................. 135
8.2.1 Genomics ...................................
..................................................
... 141 8.2.2 Global Precision Medicine Genomics
Market (by Technology) ...........................
..................................................
....... 143 Polymerase Chain Reaction
(PCR).............................................
144 Global Precision Medicine PCR Market (by
Product) ........................... 145 Global
Precision Medicine PCR Market (by End User)
......................... 146 Global Precision
Medicine PCR Market (by Region)
............................ 147 Next-Generation
Sequencing (NGS)..................................
......... 148
8.2.2.1 8.2.2.1.1 8.2.2.1.2 8.2.2.1.3 8.2.2.2
6
7
Global Precision Medicine Market
- Global Precision Medicine NGS Market (by Product)
........................... 150 - Global Precision Medicine NGS Market (by
Technology) ..................... 151 - Global Precision Medicine NGS Market (by End
User)......................... 152 - Global Precision Medicine NGS Market (by Region)
............................ 153 - 8.2.2.3 Genome Editing ...........................
...............................................
154 - Global Precision Medicine Genome Editing Market
(by Product).......... 155 - Global Precision Medicine Genome Editing Market
(by End User) ....... 156 - Global Precision Medicine Genome Editing Market
(by Region)........... 157 - 8.2.2.4 Other Technologies........................
............................................. 158 - 8.2.2.4.1 Global Precision Medicine Other
Technologies Market (by Region) ..... 159 - 8.2.3 Pharmacogenomics ...........................
............................................ 160 - 8.2.3.1 Global Precision Medicine
Pharmacogenomics Market (by Pharmacogenomics
Services) ........................................
............ 165 - Global Precision Medicine Pharmacogenomics Market
(by - End User).........................................
........................................... 166 - Global Precision Medicine Pharmacogenomics Market
(by - Region) ..........................................
............................................. 167 - 8.2.4 Other Applied Sciences .....................
............................................ 168
8.2.3.2
8.2.3.3
8.3 Precision Diagnostics.........................
..................................................
........ 169
8.3.1 Molecular Diagnostics (MDx).................
........................................
173 8.3.2 Global Precision Medicine Molecular
Diagnostics Market (by Type) .....................
..................................................
.................. 176 Non-Invasive Prenatal
Testing (NIPT)....................................
..... 177 Global Precision Medicine NIPT Market
(by Platform) ..........................
179 Global Precision Medicine NIPT Market (by
Region)............................ 180 Companion
Diagnostics ......................................
........................ 181 Global Precision
Medicine Companion Diagnostics Market (by
Technology) ......................................
..................................................
. 187 Global Precision Medicine Companion
Diagnostics Market (by Indication)
..................................................
..........................................
188 Global Precision Medicine Companion
Diagnostics Market (by Region) ...................
..................................................
........................... 189 Liquid
Biopsy............................................
................................... 190 Global
Precision Medicine Liquid Biopsy Market (by
Indication) ........... 192 Global Precision
Medicine Liquid Biopsy Market (by Region)
............... 193 Other Molecular Diagnostics
..................................................
..... 194
8.3.2.1 8.3.2.1.1 8.3.2.1.2 8.3.2.2 8.3.2.2.1
8.3.2.2.2
8.3.2.2.3
8.3.2.3 8.3.2.3.1 8.3.2.3.2 8.3.2.4
7
8
Global Precision Medicine Market
8.3.2.4.1
- Global Precision Medicine Other Molecular
Diagnostics Market (by - Type) ............................................
..................................................
..... 195 - Global Precision Medicine Other Molecular
Diagnostics Market (by Region)
..................................................
..............................................
196 - 8.3.3 Medical Imaging.............................
.................................................
197 - Global Precision Medicine Medical Imaging Market
(by Type).... 200 8.3.3.1.1 Imaging Analytics
..................................................
............................... 201 8.3.3.1.2
Imaging Computer-Aided Detection (CADx)
......................................... 202 - Global Precision Medicine Medical Imaging Market
(by - Region) ..........................................
............................................. 204
8.3.2.4.2
8.4 Digital Health and Information Technology
................................................
205
- Global Precision Medicine Digital Health and
Information Technology Market (by
Type).............................................
........... 206 - Clinical Decision Support Systems (CDSS)
................................ 207 Big Data
Analytics ........................................
............................... 209 - IT Infrastructure.................................
.......................................... 213 - Global Precision Medicine IT Infrastructure
Market (by Type) .............. 214 - Genomics Informatics .............................
.................................... 215 - Global Precision Medicine Genomics Informatics
Market (by - Product Type) ....................................
..................................................
217 - 8.4.1.5 In-Silico Informatics.....................
................................................
219 - 8.4.1.6 Mobile Health ............................
..................................................
221 - Global Precision Medicine Digital Health and
Information Technology Market (by End
User).............................................
.... 223 - Global Precision Medicine Digital Health and
Information Technology Market, (by Region)
..................................................
. 224
8.4.1.1 8.4.1.2 8.4.1.3 8.4.1.3.1 8.4.1.4 8.4.1.4.
1
8.5 Precision Therapeutics........................
..................................................
....... 225 8.5.1 Global Precision Medicine
Therapeutics Market (by Type) ........
227 8.5.1.1 Clinical Trials.......................
..................................................
...... 228 8.5.1.1.1 Global Precision Medicine
Clinical Trials Market (by Region)
............... 229 8.5.1.2 Cell
Therapy...........................................
.....................................
230 8.5.1.2.1 Global Precision Medicine Cell
Therapy Market (by Region)................
233 8.5.1.3 Drug Discovery and Research
..................................................
.. 234 8.5.1.3.1 Global Precision Medicine Drug
Discovery and Research Market (by Region),
..................................................
....................................... 236
8
9
Global Precision Medicine Market
8.5.1.4 8.5.1.4.1
Gene Therapy .....................................
........................................
237 Global Precision Medicine Drug Discovery and
Research Market (by Region) ......................
..................................................
.................. 239
9. Global Precision Medicine Market (by
Application) .....................................
....... 241 9.1 Overview ........................
..................................................
.............................. 241 9.2 Oncology...
..................................................
..................................................
. 243 9.2.1 Cancer Precision Medicine Drugs and
Indications ..................... 245
9.3 Infectious Diseases...........................
..................................................
.......... 247 9.3.1 Infectious Diseases
Precision Medicine Drugs and Indications
..................................................
....................................
249 9.4 Neurology ................................
..................................................
.................... 250 9.4.1 Neurology
Precision Medicine Drugs and Indications
................ 251 9.5 Cardiovascular
..................................................
............................................
252 9.5.1 Cardiovascular Precision Medicine
Drugs/Tests/ and Indications .....................
..................................................
............... 254 9.6 Lifestyle and
Endocrinology ....................................
....................................
255 9.6.1 Endocrinology Precision Medicine Drugs
and Indications ........ 256 9.7 Gastroenterology
.................................................
.........................................
257 9.7.1 Gastroenterology Precision Medicine
Drugs and Indications.... 258 9.8 Other
Applications .....................................
..................................................
. 259 9.8.1 Precision Drugs for Other
Applications .....................................
.. 261 10. Global Precision Medicine Market, (by
Region) ..........................................
......... 263 10.1 Overview .....................
..................................................
................................. 263 10.2 North
America ..........................................
..................................................
... 265 10.2.1 North America Precision Medicine
Market (by Ecosystem) ....... 267 10.2.2 U.S.
..................................................
................................................
269 10.2.2.1 Overview of Precision Medicine
..................................................
270 10.2.2.2 Key Trends..........................
..................................................
...... 271 10.2.2.3 Promoting Factors.............
..................................................
........ 271 10.2.2.4 Recent Key
Developments......................................
.................... 271 10.2.2.5 Funding
Scenario/Investments..............................
...................... 273 10.2.2.6 Regulatory
Scenario..........................................
.......................... 273 10.2.2.7 Key
Players ..........................................
....................................... 274
9
10
Global Precision Medicine Market
10.2.3 Canada ....................................
..................................................
...... 274 10.2.3.1 Overview of Precision
Medicine .........................................
......... 275 10.2.3.2 Key Trends.................
..................................................
............... 276 10.2.3.3 Promoting
Factors...........................................
............................ 276 10.2.3.4 Recent
Key Developments..................................
........................ 276 10.2.3.5 Regulatory
Scenario..........................................
.......................... 277 10.2.3.6 Key
Players ..........................................
....................................... 277 10.3
Europe...........................................
..................................................
............... 278 10.3.1 Europe Precision
Medicine Market (by Ecosystem) ...................
. 280 10.3.2 Germany ............................
..................................................
............ 282 10.3.2.1 Overview of Precision
Medicine .........................................
......... 283 10.3.2.2 Key Trends.................
..................................................
............... 284 10.3.2.3 Promoting
Factors...........................................
............................ 284 10.3.2.4 Recent
Key Developments..................................
........................ 284 10.3.2.5 Key Players
..................................................
...............................
285 10.3.3 France.................................
..................................................
........... 285 10.3.3.1 Overview of Precision
Medicine .........................................
......... 286 10.3.3.2 Key Trends.................
..................................................
............... 287 10.3.3.3 Promoting
Factors...........................................
............................ 287 10.3.3.4 Recent
Key Developments..................................
........................ 288 10.3.3.5 Key Players
..................................................
............................... 288 10.3.4 Italy
..................................................
................................................
288 10.3.4.1 Overview of Precision Medicine
..................................................
290 10.3.4.2 Key Trends..........................
..................................................
...... 290 10.3.4.3 Promoting Factors.............
..................................................
........ 290 10.3.4.4 Recent Key
Developments......................................
.................... 291 10.3.4.5 Funding
Scenario/Investments..............................
...................... 291 10.3.5 U.K.
..................................................
................................................
291 10.3.5.1 Overview of Precision Medicine
..................................................
292 10.3.5.2 Key Trends..........................
..................................................
...... 294 10.3.5.3 Promoting Factors.............
..................................................
........ 294 10.3.5.4 Recent Key
Developments......................................
.................... 294
10.3.5.5
Funding Scenario/Investments......................
.............................. 294
11
Global Precision Medicine Market
10.3.5.6 Key Players .............................
..................................................
.. 295 10.3.6 Spain...............................
..................................................
............... 295 10.3.6.1 Overview of
Precision Medicine ...............................
................... 297 10.3.6.2 Key
Trends............................................
......................................
297 10.3.6.3 Promoting Factors....................
..................................................
. 298 10.3.6.4 Recent Key Developments............
..............................................
298 10.3.6.5 Key Players .........................
..................................................
...... 298 10.3.7 Rest-of-Europe..................
..................................................
............ 299 10.3.7.1 Switzerland.............
..................................................
................... 300 10.4 Asia-Pacific.......
..................................................
...........................................
302 10.4.1 Asia-Pacific Precision Medicine Market
(by Ecosystem)............ 305 10.4.2 China
..................................................
............................................. 307
10.4.2.1 Overview of Precision Medicine
..................................................
308 10.4.2.2 Key Trends.........................
..................................................
....... 309 10.4.2.3 Promoting
Factors...........................................
............................ 309 10.4.2.4 Recent
Key Developments..................................
........................ 309 10.4.2.5 Key
Players ..........................................
....................................... 309
10.4.3 Japan .....................................
..................................................
........ 310 10.4.3.1 Overview of Precision
Medicine .........................................
......... 311 10.4.3.2 Key Trends................
..................................................
................ 311 10.4.3.3 Promoting
Factors...........................................
............................ 312 10.4.3.4 Recent
Key Developments..................................
........................ 312 10.4.3.5
Reimbursement Scenario............................
................................ 312 10.4.3.6
Key Players ......................................
........................................... 313
10.4.4 Australia .................................
..................................................
....... 313 10.4.4.1 Overview of Precision
Medicine .........................................
......... 314 10.4.4.2 Key Trends................
..................................................
................ 315 10.4.4.3 Promoting
Factors...........................................
............................ 315 10.4.4.4 Recent
Key Developments..................................
........................ 315 10.4.4.5 Regulatory
Scenario..........................................
.......................... 316 10.4.4.6 Key
Players ..........................................
....................................... 316
10.4.5 India .....................................
..................................................
.......... 316 10.4.5.1 Overview of
Precision Medicine ...............................
................... 318
11
12
Global Precision Medicine Market
10.4.5.2 Key Trends...............................
..................................................
. 319 10.4.5.3 Promoting Factors..................
..................................................
... 319 10.4.5.4 Recent Key Developments..........
................................................
319 10.4.5.5 Key Players .........................
..................................................
...... 320 10.4.6 Rest-of-Asia-Pacific (RoAPAC)
..................................................
... 321 10.4.6.1 Singapore........................
..................................................
.......... 322 10.4.6.1.1 Regulatory Framework
..................................................
....................... 323 10.4.6.2 South Korea
..................................................
.............................. 323 10.4.6.3 Vietna
m ................................................
....................................... 324 10.5
Latin America ....................................
..................................................
.......... 325 10.5.1 Latin America Precision
Medicine Market (by Ecosystem) ........ 327
10.5.2 Brazil.....................................
..................................................
......... 329 10.5.2.1 Overview of Precision
Medicine .........................................
......... 330 10.5.3 Mexico .....................
..................................................
...................... 331 10.5.3.1 Overview of
Precision Medicine ...............................
................... 332 10.5.3.2 Recent Key
Developments......................................
.................... 333 10.5.4
Rest-of-Latin America (RoLA) .....................
.................................. 333 10.6
Rest-of-the-World (RoW) ..........................
..................................................
.. 335 10.6.1 Rest-of-the-World Precision
Medicine Market (by Ecosystem) ...................
..................................................
................ 336 10.6.1.1 Israel
..................................................
.........................................
338 10.6.1.2 Saudi Arabia.........................
..................................................
..... 338 10.6.1.3 United Arab Emirates
..................................................
................ 339 10.6.1.4 South
Africa............................................
.....................................
340 10.6.1.5 Russia ..............................
..................................................
......... 341 11. Company Profiles
..................................................
.................................................
342 11.1 Overview ...............................
..................................................
....................... 342 11.2 Abbott
Laboratories .....................................
.................................................
343 11.2.1 Company Overview ......................
..................................................
343 11.2.2 Role of Abbott Laboratories in Global
Precision Medicine Market.........................
..................................................
................... 343 11.2.3 Financials
..................................................
......................................
344 11.2.4 Key Insights About Financial Health of
the Company ................ 347
13
Global Precision Medicine Market
11.2.5 SWOT Analysis .............................
..................................................
348 11.3 Almac Group Ltd. ......................
..................................................
.................. 349 11.3.1 Company Overview
..................................................
...................... 349 11.3.2 Role of Almac
Group Ltd. in Global Precision Medicine Market....
..................................................
........................................
349 11.3.3 SWOT Analysis .........................
..................................................
.... 350 11.4 Amgen Inc.........................
..................................................
........................... 351 11.4.1 Company
Overview .........................................
............................... 351 11.4.2 Role
of Amgen Inc. in Global Precision Medicine Market
........... 351 11.4.3 Financials
..................................................
......................................
352 11.4.4 Key Insights about Financial Health of
the Company ................. 354 11.4.5 SWOT
Analysis .........................................
...................................... 355 11.5
ANGLE plc ........................................
..................................................
........... 356 11.5.1 Company Overview
..................................................
...................... 356 11.5.2 Role of ANGLE
plc in Global Precision Medicine Market
........... 356 11.5.3 Financials
..................................................
......................................
357 11.5.4 Key Insights about Financial Health of
the Company ................. 359 11.5.5 SWOT
Analysis .........................................
...................................... 360 11.6
Astellas Pharma Inc. .............................
..................................................
...... 361 11.6.1 Company Overview
..................................................
...................... 361 11.6.2 Role of
Astellas Pharma Inc.in Global Precision
Medicine Market...................................
..................................................
......... 361 11.6.3 Financials
..................................................
......................................
362 11.6.4 Key Insights about Financial Health of
the Company ................. 363 11.6.5 SWOT
Analysis .........................................
...................................... 364 11.7
Astra Zeneca......................................
..................................................
.......... 365 11.7.1 Company Overview
..................................................
...................... 365 11.7.2 Role of Astra
Zeneca in Global Precision Medicine
Market........ 365 11.7.3 Financials
..................................................
......................................
366 11.7.4 SWOT Analysis .........................
..................................................
.... 369 11.8 ASURAGEN INC. .....................
..................................................
.................... 370 11.8.1 Company Overview
..................................................
...................... 370
14
Global Precision Medicine Market
11.8.2 Role of ASURAGEN Inc. in Global Precision
Medicine Market...................................
..................................................
......... 370 11.8.3 SWOT Analysis
..................................................
............................. 371 11.9 Bio-Rad
Laboratories, Inc.................................
............................................
372 11.9.1 Company Overview ......................
..................................................
372 11.9.2 Role of Bio-Rad Laboratories, Inc. in
Global Precision Medicine Market
..................................................
........................... 372 11.9.3 Financials
..................................................
......................................
373 11.9.4 SWOT Analysis .........................
..................................................
.... 376 11.10 bioMérieux S.A. ...................
..................................................
........................ 377 11.10.1 Company
Overview .........................................
............................... 377 11.10.2
Role of bioMérieux SA. in Global Precision
Medicine Market .... 377 11.10.3 Financials
..................................................
......................................
379 11.10.4 SWOT Analysis .......................
..................................................
...... 382 11.11 Bristol-Myers Squibb
Company...........................................
........................ 383 11.11.1 Company
Overview .........................................
............................... 383 11.11.2 Role
of Bristol-Myers Squibb Company in Global
Precision Medicine Market .......................
..................................................
.... 383 11.11.3 Financials .....................
..................................................
................. 385 11.11.4 Key Insights about
Financial Health of the Company .................
386 11.11.5 SWOT Analysis ......................
..................................................
....... 387 11.12 Cardiff Oncology
..................................................
.........................................
388 11.12.1 Company Overview ....................
..................................................
.. 388 11.12.2 Role of Cardiff Oncology in Global
Precision Medicine Market.........................
..................................................
................... 388 11.12.3 Financials
..................................................
......................................
390 11.12.4 Key Insights About Financial Health
of the Company ................ 391 11.12.5 SWOT
Analysis .........................................
...................................... 392 11.13
CETICS Healthcare Technologies GmbH
..................................................
.. 393 11.13.1 Company Overview
..................................................
...................... 393 11.13.2 Role CETICS
Healthcare Technologies GmbH in Global Precision
Medicine Market ..................................
.......................... 393 11.13.3 SWOT
Analysis .........................................
...................................... 394 11.14
Danaher Corporation ..............................
..................................................
.... 395
15
Global Precision Medicine Market
11.14.1 Company Overview .........................
...............................................
395 11.14.2 Role of Danaher Corporation in Global
Precision Medicine Market.........................
..................................................
................... 395 11.14.3 Financials
..................................................
......................................
396 11.14.4 SWOT Analysis .......................
..................................................
...... 397 11.15 Eli Lilly and Company Limited
..................................................
................... 398 11.15.1 Company Overview
..................................................
...................... 398 11.15.2 Role of Eli
Lilly and Company Limited in Global Precision
Medicine Market ..................................
...........................................
398 11.15.3 Financials ..........................
..................................................
............ 400 11.15.4 SWOT Analysis
..................................................
............................. 402 11.16 Epic
Sciences, Inc. ...................................
..................................................
... 403 11.16.1 Company Overview
..................................................
...................... 403 11.16.2 Role Epic
Sciences, Inc. in Global Precision
Medicine Market...................................
..................................................
......... 403 11.16.3 SWOT Analysis
..................................................
............................. 405 11.17 F.
Hoffmann-La Roche Ltd ............................
...............................................
406 11.17.1 Company Overview ....................
..................................................
.. 406 11.17.2 Role of F. Hoffman-LA Roche Ltd in
Global Precision Medicine Market
..................................................
........................... 406 11.17.3
Financials .......................................
.................................................
408 11.17.4 Key Insights About Financial Health
of the Company ................ 411 11.17.5 SWOT
Analysis .........................................
...................................... 412
11.18 General Electric Company....................
..................................................
...... 413 11.18.1 Company Overview
..................................................
...................... 413 11.18.2 Role of GE
Corporation in Global Precision
Medicine Market...................................
..................................................
......... 413 11.18.3 Financials
..................................................
......................................
414 11.18.4 Key Insights about Financial Health
of the Company ................. 416 11.18.5
SWOT Analysis ....................................
...........................................
417 11.19 Gilead Sciences, Inc....................
..................................................
................ 418 11.19.1 Company Overview
..................................................
...................... 418 11.19.2 Role of Gilead
Sciences, Inc. in Global Precision
Medicine Market...................................
..................................................
......... 418
16
Global Precision Medicine Market
11.19.3 SWOT Analysis ...........................
..................................................
.. 420 11.20 GlaxoSmithKline plc
..................................................
................................... 421 11.20.1
Company Overview .................................
.......................................
421 11.20.2 Role of GlaxoSmithKline Plc in Global
Precision Medicine Market.........................
..................................................
................... 421 11.20.3 Financials
..................................................
......................................
422 11.20.4 Key Insights about Financial Health
of the Company ................. 424 11.20.5
SWOT Analysis ....................................
...........................................
425 11.21 Illumina, Inc. .........................
..................................................
....................... 426 11.21.1 Company
Overview .........................................
............................... 426 11.21.2 Role
of Illumina, Inc. in Global Precision Medicine
Market......... 426 11.21.3 Financials
..................................................
......................................
428 11.21.4 Key Insights About Financial Health
of the Company ................ 430 11.21.5 SWOT
Analysis .........................................
...................................... 431 11.22
Intomics A/S .....................................
..................................................
........... 432 11.22.1 Company Overview
..................................................
...................... 432 11.22.2 Role Intomics
A/S in Global Precision Medicine Market
............. 432 11.22.3 SWOT Analysis
..................................................
............................. 433 11.23 Johnson
Johnson Services, Inc. .........................
..................................... 434
11.23.1 Company Overview .........................
...............................................
434 11.23.2 Role of Johnson and Johnson in Global
Precision Medicine Market........................
..................................................
.................... 434 11.23.3 Financials
..................................................
......................................
435 11.23.4 Key Insights about Financial Health
of the Company ................. 436 11.23.5
SWOT Analysis ....................................
...........................................
437 11.24 Konica Minolta, Inc.....................
..................................................
................. 438 11.24.1 Company Overview
..................................................
...................... 438 11.24.2 Role of Konica
Minolta, Inc. in Global Precision
Medicine Market...................................
..................................................
......... 438 11.24.3 Financials
..................................................
......................................
439 11.24.4 SWOT Analysis .......................
..................................................
...... 440 11.25 Laboratory Corporation of
America Holdings .................................
........... 441 11.25.1 Company Overview
..................................................
...................... 441
17
Global Precision Medicine Market
11.25.2 Role of Laboratory Corporation of America
Holdings in Global Precision Medicine Market
................................................
441 11.25.3 Financials ..........................
..................................................
............ 442 11.25.4 SWOT Analysis
..................................................
............................. 444 11.26 MDx
Health, Inc. .....................................
..................................................
..... 445 11.26.1 Company Overview
..................................................
...................... 445 11.26.2 Role of MDx
Health, Inc. in Global Precision
Medicine Market...................................
..................................................
......... 445 11.26.3 Financials
..................................................
......................................
446 11.26.4 SWOT Analysis .......................
..................................................
...... 447 11.27 Menarini Silicon Biosystems,
Inc. .............................................
.................. 448 11.27.1 Company Overview
..................................................
...................... 448 11.27.2 Role Menarini
Silicon Biosystems, Inc. in Global Precision
Medicine Market ..................................
...........................................
448 11.27.3 SWOT Analysis .......................
..................................................
...... 450 11.28 Merck KGaA.......................
..................................................
.......................... 451 11.28.1 Company
Overview .........................................
............................... 451 11.28.2 Role
of Merck KGaA in Global Precision Medicine Market
......... 451 11.28.3 Financials
..................................................
......................................
453 11.28.4 Key Insights About Financial Health
of the Company ................ 456 11.28.5 SWOT
Analysis .........................................
...................................... 457 11.29
Myriad Genetics, Inc. ............................
..................................................
...... 458 11.29.1 Company Overview
..................................................
...................... 458 11.29.2 Role of Myriad
Genetics, Inc. in Global Precision
Medicine Market...................................
..................................................
......... 458 11.29.3 Financials
..................................................
......................................
460 11.29.4 Key Insights About Financial Health
of the Company ................ 462 11.29.5 SWOT
Analysis .........................................
...................................... 463 11.30
Novartis AG ......................................
..................................................
........... 464 11.30.1 Company
overview..........................................
............................... 464 11.30.2 Role
of Novartis AG in Global Precision Medicine
Market ......... 464 11.30.3 Financials
..................................................
......................................
466 11.30.4 Key Insights about Financial Health
of the Company ................. 469 11.30.5
SWOT Analysis ....................................
........................................... 470
18
Global Precision Medicine Market
11.31 Oracle Corporation.........................
..................................................
............. 471 11.31.1 Company Overview
..................................................
...................... 471 11.31.2 Role of Oracle
Corporation in Global Precision
Medicine Market...................................
..................................................
......... 471 11.31.3 Financials
..................................................
......................................
472 11.31.4 Key Insights about Financial Health
of the Company ................. 474 11.31.5
SWOT Analysis ....................................
...........................................
475 11.32 Pacific Biosciences of California,
Inc...............................................
........... 476 11.32.1 Company Overview
..................................................
...................... 476 11.32.2 Role of
Pacific Biosciences of California, Inc. in
Global Precision Medicine Market
..................................................
......... 476 11.32.3 Financials
..................................................
......................................
478 11.32.4 Key Insights About Financial Health
of the Company ................ 480 11.32.5 SWOT
Analysis .........................................
...................................... 481
11.33 Partek, Inc. ...............................
..................................................
.................... 482 11.33.1 Company
Overview .........................................
............................... 482 11.33.2 Role
Partek, Inc. in Global Precision Medicine Market
............... 482 11.33.3 SWOT Analysis
..................................................
............................. 483 11.34 Pfizer
Inc. .............................................
..................................................
........ 484 11.34.1 Company Overview
..................................................
...................... 484 11.34.2 Role of
Pfizer, Inc. in Global Precision Medicine Market
............ 484 11.34.3 Financials
..................................................
......................................
486 11.34.4 Key Insights about Financial Health
of the Company ................. 489 11.34.5
SWOT Analysis ....................................
........................................... 490
11.35 QIAGEN N.V.................................
..................................................
............... 491 11.35.1 Company Overview
..................................................
...................... 491 11.35.2 Role of QIAGEN
N.V. in Global Precision Medicine Market ........
491 11.35.3 Financials .........................
..................................................
............. 493 11.35.4 Key Insights About
Financial Health of the Company ................
496 11.35.5 SWOT Analysis .......................
..................................................
...... 497 11.36 Quest Diagnostics Incorporated
..................................................
................ 498 11.36.1 Company Overview
..................................................
...................... 498
19
Global Precision Medicine Market
11.36.2 Role of Quest Diagnostics Incorporated in
Global Precision Medicine Market
..................................................
........................... 498 11.36.3
Financials .......................................
.................................................
499 11.36.4 SWOT Analysis .......................
..................................................
...... 500 11.37 Randox Laboratories
Ltd...............................................
............................... 501 11.37.1
Company Overview .................................
.......................................
501 11.37.2 Role of Randox Laboratories Ltd. in
Global Precision Medicine Market
..................................................
........................... 501 11.37.3 SWOT
Analysis .........................................
...................................... 502 11.38
Sanofi S.A. ......................................
..................................................
............. 503 11.38.1 Company Overview
..................................................
...................... 503 11.38.2 Role of Sanofi
SA in Global Precision Medicine Market
............. 503 11.38.3 Financials
..................................................
......................................
505 11.38.4 Key Insights about Financial Health
of the Company ................. 508 11.38.5
SWOT Analysis ....................................
...........................................
509 11.39 Sysmex Corporation .....................
..................................................
.............. 510 11.39.1 Company Overview
..................................................
...................... 510 11.39.2 Role of Sysmex
Corporation in Global Precision
Medicine Market...................................
..................................................
......... 510 11.39.3 Financials
..................................................
......................................
511 11.39.4 Key Insights about Financial Health
of the Company ................. 513 11.39.5
SWOT Analysis ....................................
...........................................
514 11.40 Teva Pharmaceuticals Industries Ltd.
..................................................
....... 515 11.40.1 Company Overview
..................................................
...................... 515 11.40.2 Role of Teva
Pharmaceuticals Industries Ltd. in
Global Precision Medicine Market
..................................................
......... 515 11.40.3 Financials
..................................................
......................................
516 11.40.4 Key Insights about Financial Health
of the Company ................. 518 11.40.5
SWOT Analysis ....................................
........................................... 519
11.41 Thermo Fisher Scientific Inc.
..................................................
..................... 520 11.41.1 Company
Overview .........................................
............................... 520 11.41.2 Role
of Thermo Fisher Scientific Inc. in Global
Precision Medicine Market ........................
..................................................
... 520 11.41.3 Financials ......................
..................................................
................ 522
20
Global Precision Medicine Market
11.41.4 Key Insights About Financial Health of
the Company ................ 525 11.41.5 SWOT
Analysis .........................................
...................................... 526
21
Global Precision Medicine Market
List of Figures
Figure 1 Precision Medicine Treatment Tailored
to an Individuals Genetic Structure
....................... 40 Figure 2 Precision
Medicine a Multi-Faceted Approach to Patient
Care...........................................
41 Figure 3 Decreasing Cost and Increasing
Output (TB) of Genome Sequencing (2009-2025)
........... 43 Figure 4 Impact Analysis of
Market Drivers and Market Challenges on the
Global Precision Medicine Market.................
..................................................
..........................................
Recommended
CrystalGraphics Presentations
